跳至主要内容
临床试验/NCT07200804
NCT07200804已完成不适用

Exploring the Relationship Between Serum Vitamin D and Atherosclerosis in Hemodialysis Patients: A Cross-sectional Study

Ain Shams University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
1
主要终点
Correlation between Serum Vitamin D and Atherosclerosis

研究概览

简要总结

The study aimed to check if there is a link between good vitamin D levels in the blood and subclinical atherosclerosis in people on hemodialysis.

详细描述

Hemodialysis patients with End-Stage Renal Disease (ESRD) face a significantly elevated risk of cardiovascular disease (CVD) due to a complex interplay of factors. A 30-year-old HD patient faces a cardiovascular mortality risk equivalent to that of an 80-year-old in the general population, emphasizing the accelerated aging of the cardiovascular system in ESRD.

Vitamin D may reduce inflammation and modulate immunity, lowering hypertension and dyslipidemia risks and possibly reversing vascular calcification. However, excessive supplementation can cause hypercalcemia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with end-stage renal disease (ESRD) who had been on maintenance hemodialysis for at least 6 months.
  • •Age of 18 years or older.
  • •Patients receiving three weekly dialysis sessions using a bicarbonate-based dialysate with anticoagulants.

排除标准

  • •Patients with active infections, malignancies, autoimmune diseases, or pre-existing cardiovascular conditions.
  • •Pregnancy.

结局指标

主要结局

Correlation between Serum Vitamin D and Atherosclerosis

时间窗: Immediately post-procedure (Up to 1 hour)

Correlation between Serum Vitamin D and Atherosclerosis was recorded.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ashraf Hassan

Assistant Professor of Internal Medicine and Nephrology, Faculty of Medicine, Ain shams University, Cairo, Egypt.

Ain Shams University

研究点 (1)

Loading locations...

相似试验